Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-024190
Filing Date
2025-09-10
Accepted
2025-09-10 19:33:40
Documents
1
Period of Report
2025-09-10

Document Format Files

Seq Description Document Type Size
1 form3-09102025_110936.html 3  
1 form3-09102025_110936.xml 3 6250
  Complete submission text file 0001415889-25-024190.txt   9012
Mailing Address C/O DEEP TRACK CAPITAL, LP 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830
Business Address
KROIN DAVID (Reporting) CIK: 0001397513 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42831 | Film No.: 251306926

Mailing Address 575 MADISON AVENUE NEW YORK NY 10022
Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581
LB PHARMACEUTICALS INC (Issuer) CIK: 0001691082 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Reporting) CIK: 0001856083 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42831 | Film No.: 251306927

Mailing Address C/O WALKERS CORPORATE LIMITED 190 ELGIN AVE GEORGE TOWN E9 KY1-9001
Business Address C/O WALKERS CORPORATE LIMITED 190 ELGIN AVE GEORGE TOWN E9 KY1-9001 203-409-0810
Deep Track Biotechnology Master Fund, Ltd. (Reporting) CIK: 0002015536 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42831 | Film No.: 251306928